Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Toshiyuki Tsukaguchi
Selective TRK Inhibitor CH7057288 Against TRK Fusion-Driven Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Discovery of GNF-5837, a Selective TRK Inhibitor With Efficacy in Rodent Cancer Tumor Models
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
Combating Acquired TRK Inhibitor Resistance
Cancer Discovery
Oncology
Abstract P6-20-02: Activity of Larotrectinib, a Highly Selective Inhibitor of Tropomyosin Receptor Kinase, in TRK Fusion Breast Cancers
Opioid Kappa Receptor Selective Agonist TRK-820 (Nalfurafine Hydrochloride)
Methods for Identifying Patients With Tropomyosin Receptor Kinase (TRK) Fusion Cancer
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
Tumor-Agnostic Therapy Gets on TRK
Science
Multidisciplinary
Philosophy of Science
History
TFG (TRK-fused Gene)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
ETV6-NTRK3 Induces Aggressive Acute Lymphoblastic Leukemia Highly Sensitive to Selective TRK Inhibition
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Larotrectinib OK'd for Cancers With TRK Fusions
Cancer Discovery
Oncology